Deepverge PLC Trading Update & Investor Presentation (0102H)
01 Dicembre 2020 - 08:00AM
UK Regulatory
TIDMDVRG
RNS Number : 0102H
Deepverge PLC
01 December 2020
1 December 2020
DeepVerge PLC
("DeepVerge" or "the Company")
Trading Update & Investor Presentation
DeepVerge (LSE:DVRG.L), the scientific research and
AI-as-a-Service company, is pleased to announce that guidance of
GBP4m revenues for the Company for year ending 31 December 2020
remains on track and amalgamated revenues which include Modern
Water plc, acquired on 9 November, 2020, are expected to be well
above GBP4m.
Gerry Brandon, Chief Executive Officer, will be presenting at an
investor webinar being hosted jointly by Turner Pope Investments
(TPI) Ltd and Vox Markets.
The event will be held later today, 1 December 2020 at 2pm.
Please register your interest at
https://voxmarkets.brand.live/c/deepverge-webinar
A copy of the webinar presentation will be posted on the
DeepVerge website contemporaneously.
Gerard Brandon, CEO of DeepVerge, Commented:
"The presentation will reiterate the guidance for 2020, provide
an update on sales, marketing, supply chain management of products
and services under development for a post-COVID world and I look
forward to the opportunities that are ahead for the enlarged
Group."
For further information please contact:
+44 (0) 7340 055
DeepVerge plc Gerard Brandon, CEO 648
SPARK Advisory Partners Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
Turner Pope Investments (TPI) +44 (0) 20 3657
Limited (Broker) Andy Thacker/Zoe Alexander 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is a scientific research and AI-as-a-Service company
focused on production and analysis of bacteria, virus and toxins
utilising artificial intelligent data analytics in regulatory
technology, from scientifically proving the impact of skincare
product claims on skin microbiome for top 20 global cosmetic
company clients to remotely detecting water contamination in
real-time.
In November 2020, DeepVerge acquired Modern Water who developed
and commercialised a cutting-edge technology, focused on monitoring
of contaminated water and decontamination of wastewater, making
recycling of water more efficient. Six countries across the world
have legislated that Modern Water monitoring test systems are
written into their environmental protection legislation. The
Company is in final trials for its real-time contamination product,
Microtox PD, for the identification of COVID-19 hotspots and other
pathogens.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TSTURUWRROUAOAA
(END) Dow Jones Newswires
December 01, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Integumen (LSE:SKIN)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Integumen (LSE:SKIN)
Storico
Da Mar 2023 a Mar 2024